tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5 Mama>99.0% (HPLC) Palbociclib Intermediate Factory
Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-tasi CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-tasi CAS 1013916-37-4
Igoa Vailaau | tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate |
Synonyms | 4-(6-Amino-3-Pyridyl)-1-Boc-Piperazine;1-Boc-4-(6-Amino-3-Pyridyl)piperazine;4-(6-Amino-3-pyridyl) piperazine-1-Carboxylic Acid tert-Butyl Ester;1-tert-Butoxycarbonyl-4-(6-Amino-3-pyridyl)piperazine;Palbociclib Le mama 10;Palbociclib Intermediate 1;Otava-Bb 1207229 |
Numera CAS | 571188-59-5 |
CAT Numera | RF-PI1848 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C14H22N4O2 |
Molecular Weight | 278.35 |
Lisi Lisi | 131.0 i le 135.0 ℃ |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e-Pa'epa'e i le Pa'u Samasama Malamalama |
Fa'ailoga e le HPLC | Ole taimi ole taofi ole pito maualuga ile HPLC e tatau ona o gatasi ma tulaga fa'asino |
Mama / Suʻesuʻega Metotia | >99.0% (HPLC) |
Ma'imau ile Fa'amago | <0.50% |
Toega i luga o le mumu | <0.20% |
Aofa'i Fa'aleaga | <1.00% |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Intermediate of Palbociclib (CAS: 571190-30-2) |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate (CAS: 571188-59-5) o loʻo faʻaaogaina e avea o se vailaʻau faʻapitoa.O se vaeluaga o Palbociclib (CAS: 571190-30-2).Palbociclib o se vailaʻau mo le togafitia o le kanesa o le susu ER-positive ma le HER2-negative na atiaʻe.Palbociclib o se faʻaiʻuga filifilia o le cyclin-faalagolago kinases CDK4 ma CDK6.